Hovione meets increased demand during Covid
Irish Examiner, 21 june 2021
Oops! Your browser version is not supported by our website.
Please use these following browsers to view this page:
Irish Examiner, 21 june 2021
This certification is a recognition of Hovione´s resolve to put people first, and a validation that the investment in HR excellence is delivering.
Commitment to partnership and joint innovation for cell and gene therapies
Spray drying has become one of the most successful particle engineering technologies for improving drug bioavailability through the amorphous solid dispersion platform.
Hovione today announced an extension of collaboration on Zerion’s Dispersome® technology into the nutraceutical/dietary supplements field.
Hovione commitment to setting SBTs in line with the Paris Agreement
Hovione today announced the appointment of Dr. Jean-Luc Herbeaux as Hovione’s Chief Executive Officer, effective 1st April 2022
The agreement furthers Hovione´s ability to bring the benefits of continuous tableting, including reduced time to market and increased supply chain flexibility, to pharmaceutical customers globally